ACMR combines 36% Q2 growth, a $22 billion addressable market, and $1 billion net cash—but $83.80 already prices in strong execution.
ACM Research Inc (ACMR) designs, develops, and manufactures specialized single-wafer wet cleaning, electroplating, stress-free polishing, and thermal process systems critical for high-yield integrated circuit (IC) fabrication and advanced wafer-level packaging [cite: 1, 2]. Substantially all of the company's operating assets and revenues are concentrated within mainland China, where its principal operating subsidiary, ACM Research (Shanghai), Inc. (ACM Shanghai), is publicly listed on the Shanghai Stock Exchange STAR Market [cite: 2, 3]. Operating as a platform equipment supplier, the company generates revenue through the sale of high-performance tools, ongoing field services, and the distribution of spare parts to domestic foundries, memory manufacturers, and outsourced semiconductor assembly and test (OSAT) providers [cite: 1, 4].
A breakdown of customer types reveals a balanced end-market exposure: logic and foundry customers historically represent 58.9% of the revenue mix, memory manufacturers contribute 27.3%, and advanced packaging and wafer processing accounts for 13.9% [cite: 1, 5]. Key customers include major domestic fabricators such as SMIC, Yangtze Memory Technologies (YMTC), and Huahong Group, with the top three clients collectively generating 43.5% of total revenue [cite: 3, 6].
| Dimension | Key Corporate Characteristics |
|---|---|
| Core Products | Single-wafer megasonic cleaning, electrochemical plating (ECP), vertical furnace, coater-developer Track, and PECVD systems [cite: 1, 4]. |
| Primary Customers | Pure-play foundries, Integrated Device Manufacturers (IDMs), and OSAT packaging providers [cite: 1, 7]. |
| Geographic Focus | Substantially all revenue is derived from mainland China, with ongoing expansion initiatives in South Korea, Taiwan, and Oregon [cite: 3, 8]. |
| Competitive Edge | High particle removal efficiency at sub-15nm nodes with zero structural pattern damage, combined with substantial green-chemistry acid savings [cite: 7, 9]. |
Semiconductor manufacturers select the company's tools over larger Tier-1 competitors due to its proprietary technological advantages [cite: 10, 11]. Traditional megasonic cleaning tools introduce acoustic wave cavitation that can damage delicate, high-aspect-ratio wafer features at advanced nodes [cite: 7, 12]. The company's patented Space Alternated Phase Shift (SAPS) and Timely Energized Bubble Oscillation (TEBO) technologies distribute acoustic energy uniformly, removing contaminants down to sub-15nm dimensions without pattern damage [cite: 9, 11, 13]. Additionally, the company's Ultra C Tahoe wet processing system reduces sulfuric acid consumption by 75% compared to legacy wet benches [cite: 7, 14]. This provides fabricators with lower operating costs and a direct path to satisfying green-chemistry regulatory metrics [cite: 7].
ACM Research has built out a comprehensive capital equipment portfolio organized under its "ACM Planetary Family" structure [cite: 15, 16]. This initiative expands the company's addressable market beyond simple wet cleaning into critical front-end and back-end processing steps [cite: 1, 16].
The company's competitive advantage is supported by high customer switching costs and a proprietary intellectual property portfolio [cite: 13, 21]. Once a tool is qualified for high-volume manufacturing (HMF), a process that requires multiple quarters of testing and substantial capital investment, the switching costs are very high [cite: 17, 21]. Swapping an approved tool risks localized yield disruptions, process drift, and lost revenue [cite: 7, 17].
The technical moat is protected by over 498 issued patents across global jurisdictions, including the United States, China, Japan, South Korea, Singapore, and Taiwan [cite: 11, 13]. These patents prevent competitors from replicating the phase-shifted acoustic wave delivery of the SAPS and TEBO platforms [cite: 11, 13]. In addition, the company's regional supply chain in Shanghai provides a cost advantage, allowing it to price tools competitively against Western and Japanese competitors while maintaining GAAP gross margins within its target model of 42% to 48% [cite: 13, 22, 23].
According to independent estimates from Frost & Sullivan, the global wafer fabrication equipment (WFE) market reached $142.1 billion [cite: 4]. ACM Research’s product expansion strategy has increased its Serviceable Addressable Market (SAM) to $22 billion [cite: 4].
| Equipment Category | Addressed SAM | Long-Term Market Share Target (Mainland China) | Long-Term Market Share Target (Rest of World) |
|---|---|---|---|
| Cleaning Systems | $7.4 billion | 60% | 8% to 15% [cite: 1, 4, 8] |
| PECVD Tools | $6.2 billion | 15% | 8% to 15% [cite: 1, 4, 8] |
| Track / Coater-Developer | $3.5 billion | 10% | 8% to 15% [cite: 1, 4, 8] |
| Plating Systems | $1.8 billion | 60% | 8% to 15% [cite: 1, 4, 8] |
| Furnace Equipment | $1.7 billion | 15% | 8% to 15% [cite: 1, 4, 8] |
| Advanced Packaging | $1.5 billion | Not Specified | 8% to 15% [cite: 1, 4, 8] |
The company operates alongside established Tier-1 global equipment providers, including SCREEN Holdings, Tokyo Electron Limited (TEL), and Lam Research Corporation [cite: 7, 12]. SCREEN and TEL historically held a dominant share of the global single-wafer cleaning market, while Lam Research remains the leader in electroplating [cite: 7, 24].
ACM Research has gained market share in mainland China, driven by the domestic semiconductor industry's localization initiatives [cite: 23]. In electroplating, the company has expanded its market presence, marked by shipping its 2,000th electroplating chamber in mid-2026 [cite: 14, 22]. However, in regions outside of China, the company's presence is early-stage, with limited evaluations underway at major US, European, and Taiwanese manufacturers [cite: 11, 21].
On August 7, 2026, ACM Research reported its financial results for the second quarter of 2026, which ended June 30, 2026 [cite: 3, 22].
The product mix changed during the quarter, reflecting the company's product diversification strategy [cite: 1, 5].
| Product Segment | Q2 2026 Revenue | Q2 2025 Revenue | Year-over-Year Growth | Revenue Share |
|---|---|---|---|---|
| Plating, Furnace & Other | $128.5 million | $48.0 million | +167.7% | 44.0% [cite: 1, 27] |
| Cleaning Equipment | $133.0 million | $155.0 million | -14.2% | 45.0% [cite: 1, 27] |
| Advanced Packaging & Services | $31.4 million | $12.4 million | +153.3% | 11.0% [cite: 1, 27] |
Substantially all revenue continues to be generated from customers in mainland China [cite: 3]. To support its global diversification strategy, management expects over 20 single-wafer tools to be installed at customer sites outside China across approximately 10 customers in 5 countries by the end of 2026 [cite: 22].
Insiders have been net sellers, executing 41 open-market sales and zero purchases over the past six months [cite: 25]. This activity includes transactions by CEO David Wang and CFO Mark McKechnie [cite: 25].
Following the earnings release, the stock rose 15.84% in premarket trading to $91.49 [cite: 22], before closing at $83.80, up 6.1% [cite: 16]. Wall Street analyst price targets were adjusted, with Morgan Stanley maintaining a target of $130, Roth Capital at $125, and Goldman Sachs at $164 [cite: 25, 29].
The company's long-term valuation is supported by its historical 5-year sales growth CAGR of 30.9% [cite: 30]. The balance sheet shows $1.36 billion in cash, restricted cash, and short-term deposits, alongside a net cash position of approximately $1.0 billion [cite: 28, 31].
The 5-year scenario analysis models potential equity valuations for the company through fiscal year 2031 (Year 5), using the midpoint of FY2026 revenue guidance ($1.15 billion) as the base [cite: 22, 34]. Projections incorporate a historical 5-year revenue growth rate of 30.9% and the company’s long-term business model targets [cite: 1, 30].
This scenario assumes a slowdown in capital expenditures within mainland China, combined with tightening export controls that restrict component access [cite: 21, 32]. Revenue growth slows to an 8.0% CAGR from FY26 levels, and gross margins contract due to lower capacity utilization [cite: 21, 34].
* Operating Projections: FY2031 revenue reaches $1.689 billion [cite: 34]. Net profit margins decline to 9.0%, generating net income of $152.0 million [cite: 34].
* Valuation Assumptions: Due to lower growth, the exit multiple contracts to a conservative 15.0x P/E [cite: 34]. Diluted share count increases to 78.0 million due to option dilution [cite: 34].
* Share Price Calculation:
$\text{Implied Price} = \frac{\$1,689.4\text{ million} \times 9.0\% \times 15.0}{78.0\text{ million shares}} = \$29.24\text{ USD [cite: 34]}$
This scenario assumes the company maintains its market position in mainland China, meeting its long-term localized revenue target of $2.4 billion, while establishing early-stage customer relationships in Taiwan and South Korea [cite: 1, 35].
* Operating Projections: Projections assume a 15.4% revenue growth CAGR from FY26 to FY31, with FY2031 revenue reaching $2.353 billion [cite: 34]. Net profit margins stabilize at 11.5%, generating net income of $270.6 million [cite: 34].
* Valuation Assumptions: The exit multiple is modeled at 22.0x P/E, reflecting stabilized growth [cite: 34]. Diluted share count is projected at 75.0 million [cite: 34].
* Share Price Calculation:
$\text{Implied Price} = \frac{\$2,352.7\text{ million} \times 11.5\% \times 22.0}{75.0\text{ million shares}} = \$79.36\text{ USD [cite: 34]}$
This scenario assumes the company successfully executes its global expansion strategy, meeting its long-term revenue target of $4.0 billion [cite: 1, 8]. This includes growth from the Hillsboro, Oregon manufacturing facility and market share gains in Track and PECVD systems [cite: 1, 36].
* Operating Projections: Revenue grows at an 18.0% CAGR, reaching $2.930 billion in FY2031 [cite: 34]. Net profit margins expand to 13.0%, generating net income of $381.0 million [cite: 34].
* Valuation Assumptions: The exit multiple expands to 30.0x P/E, reflecting successful geographic diversification [cite: 34]. Diluted share count is managed to 73.0 million due to share repurchases [cite: 34].
* Share Price Calculation:
$\text{Implied Price} = \frac{\$2,930.5\text{ million} \times 13.0\% \times 30.0}{73.0\text{ million shares}} = \$156.56\text{ USD [cite: 34]}$
The probability-weighted expected target price is calculated as follows [cite: 34]:
$\text{Weighted Price} = (0.20 \times \$29.24) + (0.60 \times \$79.36) + (0.20 \times \$156.56) = \$84.78\text{ USD [cite: 34]}$
| Scenario | Revenue in Year 5 (Projected) | Margin / Earnings Assumption | Valuation Multiple Assumption | Current Share Price | Implied Future Share Price (USD) | 5-Year Total Return | Annualized Return | Probability |
|---|---|---|---|---|---|---|---|---|
| Low Case | $1,689.4M | 9.0% Net Margin | 15.0x P/E | $83.80 | $29.24 | -65.11% | -18.99% | 20.0% [cite: 29, 34] |
| Base Case | $2,352.7M | 11.5% Net Margin | 22.0x P/E | $83.80 | $79.36 | -5.29% | -1.08% | 60.0% [cite: 29, 34] |
| High Case | $2,930.5M | 13.0% Net Margin | 30.0x P/E | $83.80 | $156.56 | +86.82% | +13.31% | 20.0% [cite: 29, 34] |
ASYMMETRIC GROWTH SPECTRUM
To estimate the present value of ACM Research's common equity, an unlevered Free Cash Flow to the Firm (FCFF) Discounted Cash Flow (DCF) model is used [cite: 34]. This methodology is selected to reflect the capital intensity of the business, its long-term growth outlook, and the structural subtraction required for the non-controlling interest in ACM Shanghai [cite: 31, 34].
Projections for the first five years are aligned with the 5-Year Base Case scenario [cite: 34].
* Starting Revenue (FY2026): Modeled at $1.150 billion [cite: 34], with growth normalizing from 18.0% in FY27 to 14.0% in FY31 [cite: 34].
* Operating (EBIT) Margin: Projected to expand from 16.0% in FY26 to 19.5% in FY31, reflecting operational leverage as manufacturing capacity scales at the Lingang plant [cite: 8, 34].
* Tax Rate: Projected at 11.0%, the midpoint of management's guidance of 10% to 12% [cite: 22, 34].
* Working Capital Intensity: Modeled with NWC changes absorbing 15.0% of incremental year-over-year revenue changes [cite: 34].
* SBC Add-back: Stock-based compensation is added back as a non-cash expense at 3.0% of sales [cite: 34].
* WACC: Calculated at 9.8%, using a cost of equity of 10.07% (based on a 4.74% risk-free rate, a 1.24 beta, and a 4.3% equity risk premium) and a tax-adjusted cost of debt of 5.5% [cite: 34, 37].
* Terminal Growth Rate ($g$): Projected at 3.0% [cite: 34].
| DCF Model Component | FY2026 | FY2027 | FY2028 | FY2029 | FY2030 | FY2031 |
|---|---|---|---|---|---|---|
| Revenue | $1,150.0M | $1,357.0M | $1,574.1M | $1,810.2M | $2,063.7M | $2,352.6M [cite: 34] |
| EBIT | $184.0M | $230.7M | $283.3M | $334.9M | $392.1M | $458.8M [cite: 34] |
| NOPAT | $163.8M | $205.3M | $252.1M | $298.1M | $349.0M | $408.3M [cite: 34] |
| D&A (2.1% of sales) | $24.2M | $28.5M | $33.1M | $38.0M | $43.3M | $49.4M [cite: 34] |
| CapEx | -$175.0M | -$81.4M | -$78.7M | -$72.4M | -$82.5M | -$94.1M [cite: 34] |
| Change in NWC | -$37.3M | -$31.0M | -$32.6M | -$35.4M | -$38.0M | -$43.3M [cite: 34] |
| SBC Add-back | $34.5M | $40.7M | $47.2M | $54.3M | $61.9M | $70.6M [cite: 34] |
| FCFF | $10.1M | $162.1M | $221.2M | $282.6M | $333.7M | $390.8M [cite: 34] |
A sensitivity analysis shows how the base implied price per share of $68.86 is affected by changes in the discount rate and terminal growth assumptions [cite: 34].
| WACC \ Terminal $g$ | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 8.8% | $71.35 | $75.65 | $80.70 | $86.70 | $93.95 [cite: 34] |
| 9.3% | $66.45 | $70.09 | $74.30 | $79.25 | $85.13 [cite: 34] |
| 9.8% (Base) | $62.18 | $65.29 | $68.86 | $72.99 | $77.83 [cite: 34] |
| 10.3% | $58.44 | $61.12 | $64.17 | $67.66 | $71.71 [cite: 34] |
| 10.8% | $55.13 | $57.46 | $60.08 | $63.06 | $66.49 [cite: 34] |
The sensitivity analysis yields an intrinsic value range of $55.13 to $93.95 USD [cite: 34]. The current market price of $83.80 represents a 21.7% premium over the base intrinsic value of $68.86 [cite: 29, 34].
| Intrinsic Value Metric | Value / Assumption |
|---|---|
| Valuation Methodology | Unlevered Free Cash Flow to Firm (FCFF) [cite: 34] |
| Projected 5-Year Revenue CAGR | 15.4% [cite: 34] |
| Year 5 EBIT Margin (FY2031) | 19.5% [cite: 34] |
| Year 5 Free Cash Flow | $390.8 million [cite: 34] |
| Discount Rate / WACC | 9.8% [cite: 34] |
| Terminal Growth Rate ($g$) | 3.0% [cite: 34] |
| PV of Forecast Cash Flows | $982.1 million [cite: 34] |
| PV of Terminal Value | $3,540.1 million [cite: 34] |
| Consolidated Enterprise Value | $4,522.2 million [cite: 34] |
| Net Cash / (Debt) | $1,015.0 million [cite: 28, 34] |
| Non-Controlling Interests Book Value | $545.0 million [cite: 31, 34] |
| Implied Common Equity Value | $4,992.2 million [cite: 34] |
| Diluted Shares Outstanding | 72.5 million [cite: 34] |
| Base Implied Intrinsic Value per Share | $68.86 USD [cite: 34] |
| Reasonable Intrinsic Value Range | $55.13 to $93.95 USD [cite: 34] |
| Current Share Price | $83.80 [cite: 29] |
| Premium / (Discount) to Base Intrinsic Value | 21.7% Premium [cite: 29, 34] |
FAIRLY VALUED CURRENTLY
To evaluate the qualitative elements of ACM Research's business model, the company has been scored on a scale of 1 to 10 across ten categories.
Qualitative Performance Profile:
┌─────────────────────────┬───────────────┐
│ Management Alignment │ ■■■■■■■■── 8 │
│ Revenue Quality │ ■■■■────── 4 │
│ Market Position │ ■■■■■■■─── 7 │
│ Growth Outlook │ ■■■■■■■■■─ 9 │
│ Financial Health │ ■■■■■■■■■─ 9 │
│ Business Viability │ ■■■■■───── 5 │
│ Capital Allocation │ ■■■■■■──── 6 │
│ Analyst Sentiment │ ■■■■■■■■── 8 │
│ Profitability │ ■■■■■■■─── 7 │
│ Track Record │ ■■■■■■■■── 8 │
└─────────────────────────┴───────────────┘
The overall qualitative assessment yields a blended score of 7.1 out of 10, reflecting strong financial health and robust secular growth tailwinds, balanced against geopolitical exposures and customer concentration risks [cite: 3, 32].
ROBUST GROWTH ENCLAVE
ACM Research is successfully transitioning from a single-product tool provider into a diversified, multi-product semiconductor equipment platform [cite: 1, 16]. By expanding its serviceable addressable market (SAM) to $22 billion across six major equipment categories, the company is capturing market share in China's domestic semiconductor buildout [cite: 4, 23]. This growth is supported by strong near-term indicators, including a 105% year-over-year increase in first-half 2026 orders and a raised full-year revenue guidance midpoint of $1.15 billion [cite: 22, 28].
The company's technology differentiation, such as its SAPS, TEBO, and Tahoe architectures, provides a competitive moat by improving manufacturing yields and reducing chemical consumption for major foundries [cite: 7, 13]. These localized advantages are balanced by a strong balance sheet featuring $1.0 billion in net cash [cite: 20, 28].
However, the investment thesis must balance these operational successes against structural risks [cite: 16, 32]. Geopolitical tensions and export control policies are an ongoing factor for its mainland China operations [cite: 3, 32]. Additionally, high customer concentration—where the top three customers account for 43.5% of quarterly revenue—means performance is closely tied to the spending cycles of a few key manufacturers [cite: 3]. Working capital constraints, driven by inventory expansion to $783.1 million, also continue to impact free cash flow generation [cite: 27, 32].
The valuation analysis shows that at a current price of $83.80, the stock is trading at a premium to its calculated Base Case intrinsic value of $68.86 [cite: 16, 34]. This valuation suggests the market is pricing in a favorable scenario for both the domestic Chinese market and international expansion, including the Oregon facility opening in late 2026 [cite: 8, 36]. For the valuation to align with a higher range, the company will likely need to show sustained margin stabilization, successful customer acceptance of new platforms (such as Track and PECVD), and progress in diversifying its customer base globally [cite: 21, 32].
MONITOR EXPANSION EXECUTION
ACM Research's stock is trading at $83.80, positioned in the middle of its 52-week range of $23.59 to $127.19 [cite: 22, 41]. The stock is trading near its 50-day moving average of $79.79 but remains below its 200-day moving average of $90.49 [cite: 42]. While the company's strong Q2 results and updated guidance provide fundamental support, the stock's short-term outlook is expected to be influenced by macroeconomic trends, technology sector rotations, and ongoing trade policy developments [cite: 22, 32].
MOMENTUM RANGE CONSOLIDATION
View ACM Research, Inc. (ACMR) stock page
Loading the interactive version of this report…